ROCKVILLE, Md., Sept. 30, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced today that GtreeBNT, its Korean partner in the U.S. development of RGN-259 for the treatment of dry eye disease, issued an updat

CLEVELAND, Sept. 30, 2019 /PRNewswire/ -- The National Cybersecurity Center of Excellence (NCCoE) at the National Institute of Standards and Technology (NIST) is releasing a new practice guide – NIST Special Publication 1800-24, Securing Picture Archiving and Communication System (PACS) – to help healthcare delivery organizations (HDOs) protect patient

LAUSANNE, Switzerland, Sept. 30, 2019 /PRNewswire/ -- Debiopharm, a Swiss-based global biopharmaceutical company, presented today, at the ESMO Congress (European Society for Medical Oncology), compelling results from a robust, randomized, Phase II study of Debio 1143 for the treatment of high-risk, locally advanced squamous cell carc

NEW YORK and MELBOURNE, Australia, Sept. 30, 2019 /PRNewswire/ -- Benitec Biopharma Limited (ASX:BLT; NASDAQ:BNTC; NASDAQ:BNTCW) ("Benitec" or the "Company") announces it has entered into a securities purchase agreement ("SPA") with certain sophisticated and professional investors in the United States

CHICAGO, Sept. 30, 2019 /PRNewswire/ -- Zing Health Choice IL, a new community-focused, tech-enabled Medicare Advantage HMO plan available to Cook County residents starting in 2020, will feature a hands-on and data-driven approach offering members personal guidance through the complicated and stressful process of optimizing thei

ALHAMBRA, Calif., Sept. 30, 2019 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, today announced the appointment of Matthew Mazdyasni to its Board of Directors and Brandon Sim as its Interim Chief Technology Officer.Mr. Mazdyasni cur

AURORA, Colo., Sept. 30, 2019 /PRNewswire/ -- United by a mission to remove barriers, advance research and improve lives, the  Unive

REDWOOD CITY, Calif., Sept. 30, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from a new analysis of the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, which reinforce the unique value of the Oncotype DX Breast Recurrence Score® test to guide the use of adjuvant chemotherapy for

MCLEAN, Va., Sept. 30, 2019 /PRNewswire/ -- Today, FARE (Food Allergy Research & Education), the world's largest private funder of food allergy research, announced Steve Danon as its new senior vice president of external affairs. Danon will lead the organization's efforts to engage with opinion leaders, media, decision makers and s

BALTIMORE, Sept. 30, 2019 /PRNewswire/ -- Sage Growth Partners (SGP), a Baltimore-based healthcare research, strategy, and marketing firm, today announced that it has been renewed by It's Never 2 Late (iN2L) as the company's marketing agency of record. A leading provider of senior engagement technology, iN2L's content-dri